|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019682,
umls-concept:C0019693,
umls-concept:C0019699,
umls-concept:C0181586,
umls-concept:C0301625,
umls-concept:C0598312,
umls-concept:C0806909,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2000-8-22
|
|
pubmed:abstractText |
It is predicted that HIV-infected individuals in early HIV disease are the most likely group to achieve immune reconstitution following highly active antiretroviral treatment. We assessed whether suppression of HIV replication in this group would improve immune function.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
761-70
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10839583-Adolescent,
pubmed-meshheading:10839583-Adult,
pubmed-meshheading:10839583-Anti-HIV Agents,
pubmed-meshheading:10839583-CD4 Lymphocyte Count,
pubmed-meshheading:10839583-CD8-Positive T-Lymphocytes,
pubmed-meshheading:10839583-Cytokines,
pubmed-meshheading:10839583-Drug Therapy, Combination,
pubmed-meshheading:10839583-HIV Infections,
pubmed-meshheading:10839583-HIV-1,
pubmed-meshheading:10839583-Humans,
pubmed-meshheading:10839583-Indinavir,
pubmed-meshheading:10839583-Lamivudine,
pubmed-meshheading:10839583-Lymphocyte Activation,
pubmed-meshheading:10839583-RNA, Viral,
pubmed-meshheading:10839583-Reverse Transcriptase Inhibitors,
pubmed-meshheading:10839583-Time Factors,
pubmed-meshheading:10839583-Viral Load,
pubmed-meshheading:10839583-Virus Replication,
pubmed-meshheading:10839583-Zidovudine
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
|
|
pubmed:affiliation |
Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
